Alternatively, treatment of lung adenocarcinoma with cisplatin enhances IL-11 secretion by CAFs, which in turn promotes resistance of cancer cells to CT through the STAT-3 signaling pathway (Tao et al., 2016). The gene discussed is STAT3; the disease is cancer.